vs

Side-by-side financial comparison of Caribou Biosciences, Inc. (CRBU) and MOVING iMAGE TECHNOLOGIES INC. (MITQ). Click either name above to swap in a different company.

Caribou Biosciences, Inc. is the larger business by last-quarter revenue ($3.9M vs $3.8M, roughly 1.0× MOVING iMAGE TECHNOLOGIES INC.). MOVING iMAGE TECHNOLOGIES INC. runs the higher net margin — -10.2% vs -672.1%, a 661.9% gap on every dollar of revenue. On growth, Caribou Biosciences, Inc. posted the faster year-over-year revenue change (89.7% vs 10.2%). Over the past eight quarters, Caribou Biosciences, Inc.'s revenue compounded faster (27.4% CAGR vs 7.8%).

Caribou Biosciences, Inc. is a clinical-stage biotechnology company focused on developing CRISPR genome-edited cell therapies for cancers and autoimmune diseases. It operates mainly in North American and European markets, partnering with leading pharmaceutical enterprises to advance its pipeline of accessible, targeted therapeutic products for global patients.

Silicon Image Inc. was an American fabless semiconductor company based in Hillsboro, Oregon, and active from 1995 to 2015. The company designed circuits for mobile phones, consumer electronics and personal computers (PCs). It also manufactured wireless and wired connectivity products used for high-definition content. The company's semiconductor and IP products were deployed by manufacturers in devices such as smartphones, tablets, digital televisions (DTVs), and other consumer electronics, as...

CRBU vs MITQ — Head-to-Head

Bigger by revenue
CRBU
CRBU
1.0× larger
CRBU
$3.9M
$3.8M
MITQ
Growing faster (revenue YoY)
CRBU
CRBU
+79.5% gap
CRBU
89.7%
10.2%
MITQ
Higher net margin
MITQ
MITQ
661.9% more per $
MITQ
-10.2%
-672.1%
CRBU
Faster 2-yr revenue CAGR
CRBU
CRBU
Annualised
CRBU
27.4%
7.8%
MITQ

Income Statement — Q4 FY2025 vs Q2 FY2026

Metric
CRBU
CRBU
MITQ
MITQ
Revenue
$3.9M
$3.8M
Net Profit
$-26.5M
$-388.0K
Gross Margin
30.7%
Operating Margin
-722.0%
-10.8%
Net Margin
-672.1%
-10.2%
Revenue YoY
89.7%
10.2%
Net Profit YoY
25.4%
26.4%
EPS (diluted)
$-0.28
$-0.04

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CRBU
CRBU
MITQ
MITQ
Q4 25
$3.9M
$3.8M
Q3 25
$2.2M
$5.6M
Q2 25
$2.7M
Q1 25
$2.4M
$3.6M
Q4 24
$2.1M
$3.4M
Q3 24
$2.0M
$5.3M
Q2 24
$3.5M
$6.3M
Q1 24
$2.4M
$3.9M
Net Profit
CRBU
CRBU
MITQ
MITQ
Q4 25
$-26.5M
$-388.0K
Q3 25
$-27.5M
$509.0K
Q2 25
$-54.1M
Q1 25
$-40.0M
$-240.0K
Q4 24
$-527.0K
Q3 24
$-34.7M
$-25.0K
Q2 24
$-37.7M
$-416.0K
Q1 24
$-41.2M
$-601.0K
Gross Margin
CRBU
CRBU
MITQ
MITQ
Q4 25
30.7%
Q3 25
30.0%
Q2 25
Q1 25
29.8%
Q4 24
27.2%
Q3 24
26.1%
Q2 24
22.5%
Q1 24
17.4%
Operating Margin
CRBU
CRBU
MITQ
MITQ
Q4 25
-722.0%
-10.8%
Q3 25
-1337.6%
6.3%
Q2 25
-1784.0%
Q1 25
-1823.8%
-7.6%
Q4 24
-16.3%
Q3 24
-1889.2%
-1.3%
Q2 24
-1255.8%
-7.3%
Q1 24
-1893.9%
-16.7%
Net Margin
CRBU
CRBU
MITQ
MITQ
Q4 25
-672.1%
-10.2%
Q3 25
-1253.3%
9.1%
Q2 25
-2028.4%
Q1 25
-1699.6%
-6.7%
Q4 24
-15.3%
Q3 24
-1713.6%
-0.5%
Q2 24
-1088.3%
-6.6%
Q1 24
-1697.6%
-15.4%
EPS (diluted)
CRBU
CRBU
MITQ
MITQ
Q4 25
$-0.28
$-0.04
Q3 25
$-0.30
$0.05
Q2 25
$-0.58
Q1 25
$-0.43
$-0.02
Q4 24
$-0.05
Q3 24
$-0.38
$0.00
Q2 24
$-0.42
$-0.04
Q1 24
$-0.46
$-0.06

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CRBU
CRBU
MITQ
MITQ
Cash + ST InvestmentsLiquidity on hand
$12.4M
Total DebtLower is stronger
Stockholders' EquityBook value
$122.2M
$5.0M
Total Assets
$175.4M
$9.5M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CRBU
CRBU
MITQ
MITQ
Q4 25
$12.4M
Q3 25
$11.1M
Q2 25
$25.2M
Q1 25
$29.4M
Q4 24
$16.3M
Q3 24
$32.0M
Q2 24
$37.9M
Q1 24
$49.4M
Stockholders' Equity
CRBU
CRBU
MITQ
MITQ
Q4 25
$122.2M
$5.0M
Q3 25
$141.8M
$5.4M
Q2 25
$166.1M
Q1 25
$217.2M
$5.0M
Q4 24
$253.0M
$5.2M
Q3 24
$281.2M
$5.7M
Q2 24
$310.5M
$5.7M
Q1 24
$343.3M
$6.3M
Total Assets
CRBU
CRBU
MITQ
MITQ
Q4 25
$175.4M
$9.5M
Q3 25
$195.0M
$11.3M
Q2 25
$220.9M
Q1 25
$273.7M
$11.2M
Q4 24
$313.3M
$10.0M
Q3 24
$344.3M
$10.7M
Q2 24
$372.9M
$10.5M
Q1 24
$406.8M
$12.7M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CRBU
CRBU
MITQ
MITQ
Operating Cash FlowLast quarter
$-20.8M
$-1.6M
Free Cash FlowOCF − Capex
$-21.0M
FCF MarginFCF / Revenue
-533.9%
Capex IntensityCapex / Revenue
5.5%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-112.8M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CRBU
CRBU
MITQ
MITQ
Q4 25
$-20.8M
$-1.6M
Q3 25
$-25.2M
$-167.0K
Q2 25
$-28.3M
Q1 25
$-36.7M
$53.0K
Q4 24
$-138.2M
$70.0K
Q3 24
$-32.7M
$-32.0K
Q2 24
$-32.9M
$-472.0K
Q1 24
$-37.2M
$1.0M
Free Cash Flow
CRBU
CRBU
MITQ
MITQ
Q4 25
$-21.0M
Q3 25
$-25.3M
Q2 25
$-28.7M
Q1 25
$-37.8M
Q4 24
$-143.1M
Q3 24
$-33.3M
Q2 24
$-35.1M
Q1 24
$-38.7M
FCF Margin
CRBU
CRBU
MITQ
MITQ
Q4 25
-533.9%
Q3 25
-1151.0%
Q2 25
-1075.2%
Q1 25
-1605.1%
Q4 24
-6888.8%
Q3 24
-1646.9%
Q2 24
-1013.5%
Q1 24
-1591.2%
Capex Intensity
CRBU
CRBU
MITQ
MITQ
Q4 25
5.5%
Q3 25
5.2%
Q2 25
15.7%
Q1 25
44.3%
Q4 24
235.0%
Q3 24
33.3%
Q2 24
64.7%
0.0%
Q1 24
59.6%
0.0%
Cash Conversion
CRBU
CRBU
MITQ
MITQ
Q4 25
Q3 25
-0.33×
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons